Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Metformin (850mg) + Linagliptin (2.5mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Metfoam L Tablet containing Metformin and Linagliptin is used for the management of type 2 diabetes mellitus. It helps in controlling blood sugar levels and improving overall glycemic control.
Metformin works by reducing glucose production in the liver and improving insulin sensitivity, while Linagliptin enhances insulin secretion by inhibiting DPP-4 enzyme.
The tablet is widely prescribed in diabetic care for long-term management, often used as combination therapy when single agents are not sufficient, leading to consistent demand and repeat usage.
With increasing prevalence of diabetes and growing need for effective combination therapies, this product offers strong business potential for retailers and distributors. Its chronic therapy requirement, steady prescription demand, and wide clinical acceptance make it a reliable product for consistent sales and growth in the anti-diabetic segment.
Some patients may experience nausea, diarrhea, abdominal discomfort, headache, or mild hypoglycemia (when combined with other antidiabetics). Rarely, lactic acidosis (from Metformin) or pancreatitis may occur and require immediate medical attention.
Metfoam L Tablet is indicated for the treatment of type 2 diabetes mellitus, especially in patients who require dual therapy for better glycemic control. It helps reduce fasting and postprandial blood glucose levels, improve insulin response, and lower the risk of diabetes-related complications.
This medicine should be used under medical supervision along with proper diet and exercise. Regular monitoring of blood glucose and kidney function is recommended. Patients should avoid excessive alcohol intake to reduce risk of lactic acidosis.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Composition : Empagliflozin (25mg) + Sitagliptin (100mg) Tablet
Composition : Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)
Composition : Empagliflozin (10mg) Tablet
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (12.5mg) + Metformin (500mg)
Composition : Empagliflozin (25mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Metfoam L Tablet, containing Metformin 850mg and Linagliptin 2.5mg, has strong demand in the diabetes care segment, making it a high-volume product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-diabetic and chronic disease management portfolios.
Medical distributors and agencies can benefit from the consistent demand for combination oral anti-diabetic therapy used in type 2 diabetes mellitus management. Metfoam L Tablet helps strengthen a comprehensive diabetic care product portfolio with widely prescribed dual-action therapy.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Metfoam L Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong chronic prescription demand, long-term market stability, reliable supply chain support, and professional assistance when partnering for Metfoam L Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Metfoam L Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.